Thomson Medical A50

SGD 0.046 -4.35% 0.00 Updated 6 Nov 2026, 17:16 SGT

Financials

Thomson Medical Group Limited Annual Report 2026

Open annual report

Explore the statements

15 tables

Consolidated Profit or Loss

14 metrics

Units appear below each metric. Scroll to compare years

Consolidated Profit or Loss from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Consolidated Profit or Loss
RevenueSGD thousand 420,080394,658 PDF p. 146
Other incomeSGD thousand 6,50860,869 PDF p. 146
Inventories and consumables usedSGD thousand (110,221)(99,329) PDF p. 146
Staff costsSGD thousand (140,863)(135,491) PDF p. 146
Depreciation and amortisation expensesSGD thousand (40,982)(38,685) PDF p. 146
Other operating expensesSGD thousand (108,224)(166,116) PDF p. 146
Profit from operating activitiesSGD thousand 26,29815,906 PDF p. 146
Finance incomeSGD thousand 1,7973,616 PDF p. 146
Finance costsSGD thousand (49,203)(59,656) PDF p. 146
Net finance costsSGD thousand (47,406)(56,040) PDF p. 146
Share of results of joint venture and associateSGD thousand (17)(483) PDF p. 146
Loss before taxationSGD thousand (21,125)(40,617) PDF p. 146
Income tax expenseSGD thousand (6,665)(6,363) PDF p. 146
Loss for the yearSGD thousand (27,790)(46,980) PDF p. 146
Definitions & sources

Consolidated Comprehensive Income and Attribution

12 metrics

Units appear below each metric. Scroll to compare years

Consolidated Comprehensive Income and Attribution from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Consolidated Comprehensive Income and Attribution
Loss for the yearSGD thousand (27,790)(46,980) PDF p. 147
Foreign currency translationSGD thousand 8,43921,774 PDF p. 147
Net change in fair value of cash flow hedgesSGD thousand 243(767) PDF p. 147
Net change in fair value of financial assets at fair value through other comprehensive incomeSGD thousand (3,400)1,562 PDF p. 147
Other comprehensive income for the year, net of taxSGD thousand 5,28222,569 PDF p. 147
Total comprehensive income for the yearSGD thousand (22,508)(24,411) PDF p. 147
Loss attributable to owners of the CompanySGD thousand (29,703)(47,576) PDF p. 147
Profit attributable to non-controlling interestsSGD thousand 1,913596 PDF p. 147
Total loss attributionSGD thousand (27,790)(46,980) PDF p. 147
Total comprehensive income attributable to owners of the CompanySGD thousand (28,563)(29,101) PDF p. 147
Total comprehensive income attributable to non-controlling interestsSGD thousand 6,0554,690 PDF p. 147
Total comprehensive income attributionSGD thousand (22,508)(24,411) PDF p. 147
Definitions & sources

Basic and Diluted Earnings per Share

1 metrics

Units appear below each metric. Scroll to compare years

Basic and Diluted Earnings per Share from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Basic and Diluted Earnings per Share
Basic and diluted earnings per shareSGD cents per share (0.112)(0.180) PDF p. 147
Definitions & sources

Statements of Financial Position — Assets and Current Liabilities

25 metrics

Units appear below each metric. Scroll to compare years

Statements of Financial Position — Assets and Current Liabilities from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group2026Company2025Company Source
Statements of Financial Position — Assets and Current Liabilities
Property and equipmentSGD thousand 486,782483,454181232 PDF p. 148
Intangible assetsSGD thousand 791,452825,013–– PDF p. 148
Investment propertiesSGD thousand 144,001137,036–– PDF p. 148
Right-of-use assetsSGD thousand 26,15215,276310575 PDF p. 148
Investment in subsidiariesSGD thousand ––2,295,2872,281,775 PDF p. 148
Investment in joint ventureSGD thousand –17–– PDF p. 148
Investment in associateSGD thousand –––– PDF p. 148
Other receivableSGD thousand 1,272––– PDF p. 148
Deferred tax assetsSGD thousand 329359–– PDF p. 148
Other investmentSGD thousand 4793,879–– PDF p. 148
Total non-current assetsSGD thousand 1,450,4671,465,0342,295,7782,282,582 PDF p. 148
Development propertySGD thousand 135,539128,940–– PDF p. 148
InventoriesSGD thousand 12,2289,880–– PDF p. 148
Trade and other receivablesSGD thousand 62,89556,518945,371945,105 PDF p. 148
Cash and short-term depositsSGD thousand 113,083124,21124,86725,783 PDF p. 148
Total current assetsSGD thousand 323,745319,549970,238970,888 PDF p. 148
Total assetsSGD thousand 1,774,2121,784,5833,266,0163,253,470 PDF p. 148
Current contract liabilitiesSGD thousand 5,4115,777–– PDF p. 148
Current trade and other payablesSGD thousand 87,56584,2536,0776,483 PDF p. 148
Income tax payableSGD thousand 5,9327,24116271 PDF p. 148
Current interest-bearing loans and borrowingsSGD thousand 201,845163,943187,50097,433 PDF p. 148
Current lease liabilitiesSGD thousand 10,1857,553290271 PDF p. 148
Current derivative financial instrumentsSGD thousand 79–79– PDF p. 148
Total current liabilitiesSGD thousand 311,017268,767193,962104,458 PDF p. 148
Net current assetsSGD thousand 12,72850,782776,276866,430 PDF p. 148
Definitions & sources

Statements of Financial Position — Non-current Liabilities and Equity

16 metrics

Units appear below each metric. Scroll to compare years

Statements of Financial Position — Non-current Liabilities and Equity from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group2026Company2025Company Source
Statements of Financial Position — Non-current Liabilities and Equity
Non-current contract liabilitiesSGD thousand 597407–– PDF p. 149
Deferred tax liabilitiesSGD thousand 17,49114,937–– PDF p. 149
Non-current interest-bearing loans and borrowingsSGD thousand 901,973941,968635,176731,422 PDF p. 149
Non-current lease liabilitiesSGD thousand 15,9818,10237326 PDF p. 149
Provision for restoration costsSGD thousand 1,2981,2823535 PDF p. 149
Non-current derivative financial instrumentsSGD thousand 369691369691 PDF p. 149
Total non-current liabilitiesSGD thousand 937,709967,387635,617732,474 PDF p. 149
Total liabilitiesSGD thousand 1,248,7261,236,154829,579836,932 PDF p. 149
Net assetsSGD thousand 525,486548,4292,436,4372,416,538 PDF p. 149
Share capitalSGD thousand 2,364,6972,364,5032,364,6972,364,503 PDF p. 149
Retained earningsSGD thousand 82,036111,34072,18852,205 PDF p. 149
Other reservesSGD thousand (2,004,329)(2,004,948)(448)(170) PDF p. 149
Equity attributable to owners of the CompanySGD thousand 442,404470,8952,436,4372,416,538 PDF p. 149
Non-controlling interestsSGD thousand 83,08277,534–– PDF p. 149
Total equitySGD thousand 525,486548,4292,436,4372,416,538 PDF p. 149
Total equity and liabilitiesSGD thousand 1,774,2121,784,5833,266,0163,253,470 PDF p. 149
Definitions & sources

Consolidated Cash Flows — Operating Activities

28 metrics

Units appear below each metric. Scroll to compare years

Consolidated Cash Flows — Operating Activities from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Consolidated Cash Flows — Operating Activities
Loss before taxationSGD thousand (21,125)(40,617) PDF p. 153
Allowance for/(writeback of) expected credit losses on trade receivables, netSGD thousand 127(30) PDF p. 153
Amortisation of financing fees on borrowingsSGD thousand 1,099997 PDF p. 153
Depreciation of property and equipment and investment propertiesSGD thousand 25,26223,824 PDF p. 153
Depreciation of right-of-use assetsSGD thousand 9,3809,014 PDF p. 153
Amortisation of intangible assetsSGD thousand 6,3405,847 PDF p. 153
Loss on disposal of property and equipmentSGD thousand 33139 PDF p. 153
Property and equipment written offSGD thousand 1691 PDF p. 153
Inventories written offSGD thousand 11449 PDF p. 153
Gain on derecognition of leasesSGD thousand (3)(4) PDF p. 153
Finance incomeSGD thousand (1,797)(3,616) PDF p. 153
Finance costsSGD thousand 48,10458,659 PDF p. 153
Share of results of joint venture and associateSGD thousand 17483 PDF p. 153
Unrealised exchange (gain)/lossSGD thousand (836)524 PDF p. 153
Impairment loss on goodwillSGD thousand 15,24575,134 PDF p. 153
Equity-settled share-based payment transactionsSGD thousand 72(195) PDF p. 153
Reversal of impairment loss on development propertySGD thousand –(26,593) PDF p. 153
Reversal of impairment loss on investment propertiesSGD thousand –(28,024) PDF p. 153
Total adjustmentsSGD thousand 103,173116,299 PDF p. 153
Operating cash flows before changes in working capitalSGD thousand 82,04875,682 PDF p. 153
Increase in inventoriesSGD thousand (2,187)(1,197) PDF p. 153
Increase in trade and other receivablesSGD thousand (9,804)(12,629) PDF p. 153
Increase in trade and other payables and contract liabilitiesSGD thousand 1,3122,536 PDF p. 153
Total changes in working capitalSGD thousand (10,679)(11,290) PDF p. 153
Cash flows from operationsSGD thousand 71,36964,392 PDF p. 153
Interest income receivedSGD thousand 1,6253,656 PDF p. 153
Income taxes paidSGD thousand (2,029)(7,600) PDF p. 153
Net cash flows generated from operating activitiesSGD thousand 70,96560,448 PDF p. 153
Definitions & sources

Consolidated Cash Flows — Investing, Financing and Reconciliation

16 metrics

Units appear below each metric. Scroll to compare years

Consolidated Cash Flows — Investing, Financing and Reconciliation from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Consolidated Cash Flows — Investing, Financing and Reconciliation
Purchase of property and equipmentSGD thousand (15,321)(22,583) PDF p. 154
Purchase of intangible assetsSGD thousand (4,663)(4,078) PDF p. 154
Proceeds from disposal of property and equipmentSGD thousand 2373 PDF p. 154
Additional investment in joint ventureSGD thousand –(500) PDF p. 154
Net cash flows used in investing activitiesSGD thousand (19,747)(27,158) PDF p. 154
Repayment of interest-bearing loans and borrowingsSGD thousand (184,499)(450,610) PDF p. 154
Proceeds from interest-bearing loans and borrowingsSGD thousand 178,625446,275 PDF p. 154
Changes in pledged depositsSGD thousand 2,2156,847 PDF p. 154
Dividends paid to non-controlling interests of subsidiariesSGD thousand (507)(3,869) PDF p. 154
Payment of principal portion of lease liabilitiesSGD thousand (9,713)(8,849) PDF p. 154
Interest paidSGD thousand (48,787)(60,987) PDF p. 154
Net cash flows used in financing activitiesSGD thousand (62,666)(71,193) PDF p. 154
Net decrease in cash and cash equivalentsSGD thousand (11,448)(37,903) PDF p. 154
Effect of exchange rate changes on cash and cash equivalentsSGD thousand 2,5351,685 PDF p. 154
Cash and cash equivalents at beginning of the yearSGD thousand 114,019150,237 PDF p. 154
Cash and cash equivalents at end of the yearSGD thousand 105,106114,019 PDF p. 154
Definitions & sources

Group Equity Movements 2026

14 metrics

Units appear below each metric. Scroll to compare years

Group Equity Movements 2026 from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026GroupTotal equity2026GroupEquity attributable to owners2026GroupShare capital2026GroupMerger reserve2026GroupForeign currency translation reserve2026GroupCapital reserve2026GroupFair value reserve2026GroupShare-based payment reserve2026GroupHedging reserve2026GroupRetained earnings2026GroupNon-controlling interests Source
Group equity movements
Opening balance at 1 July 2025SGD thousand 548,429470,8952,364,503(1,842,369)(117,800)(47,128)2,519521(691)111,34077,534 PDF p. 150
(Loss)/profit for the yearSGD thousand (27,790)(29,703)–––––––(29,703)1,913 PDF p. 150
Foreign currency translationSGD thousand 8,4394,297––4,297–––––4,142 PDF p. 150
Net change in fair value of cash flow hedgesSGD thousand 243243––––––243–– PDF p. 150
Net change in fair value of financial assets at fair value through other comprehensive incomeSGD thousand (3,400)(3,400)––––(3,400)–––– PDF p. 150
Other comprehensive income for the year, net of taxSGD thousand 5,2821,140––4,297–(3,400)–243–4,142 PDF p. 150
Total comprehensive income for the yearSGD thousand (22,508)(28,563)––4,297–(3,400)–243(29,703)6,055 PDF p. 150
Equity-settled share-based payment transactionsSGD thousand 7272–––––72––– PDF p. 150
Vesting of shares under Share Grant Plan 2015SGD thousand ––194––––(194)––– PDF p. 150
Dividends paid to non-controlling interests of subsidiariesSGD thousand (507)–––––––––(507) PDF p. 150
Total contributions by and distributions to ownersSGD thousand (435)72194––––(122)––(507) PDF p. 150
Transfer of share-based payment reserveSGD thousand –––––––(399)–399– PDF p. 150
Total othersSGD thousand –––––––(399)–399– PDF p. 150
Closing balance at 30 June 2026SGD thousand 525,486442,4042,364,697(1,842,369)(113,503)(47,128)(881)–(448)82,03683,082 PDF p. 150
Definitions & sources

Group Equity Movements 2025

15 metrics

Units appear below each metric. Scroll to compare years

Group Equity Movements 2025 from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2025GroupTotal equity2025GroupEquity attributable to owners2025GroupShare capital2025GroupMerger reserve2025GroupForeign currency translation reserve2025GroupCapital reserve2025GroupFair value reserve2025GroupShare-based payment reserve2025GroupHedging reserve2025GroupRetained earnings2025GroupNon-controlling interests Source
Group equity movements
Opening balance at 1 July 2024SGD thousand 576,995499,7222,364,503(1,842,369)(135,480)(47,128)95772276158,44177,273 PDF p. 151
(Loss)/profit for the yearSGD thousand (46,980)(47,576)–––––––(47,576)596 PDF p. 151
Foreign currency translationSGD thousand 21,77417,680––17,680–––––4,094 PDF p. 151
Net change in fair value of cash flow hedgesSGD thousand (767)(767)––––––(767)–– PDF p. 151
Net change in fair value of financial assets at fair value through other comprehensive incomeSGD thousand 1,5621,562––––1,562–––– PDF p. 151
Other comprehensive income for the year, net of taxSGD thousand 22,56918,475––17,680–1,562–(767)–4,094 PDF p. 151
Total comprehensive income for the yearSGD thousand (24,411)(29,101)––17,680–1,562–(767)(47,576)4,690 PDF p. 151
Equity-settled share-based payment transactionsSGD thousand (195)(201)–––––(201)––6 PDF p. 151
Dividends paid to non-controlling interests of subsidiariesSGD thousand (3,869)–––––––––(3,869) PDF p. 151
Total contributions by and distributions to ownersSGD thousand (4,064)(201)–––––(201)––(3,863) PDF p. 151
Liquidation of a subsidiarySGD thousand (91)–––––––––(91) PDF p. 151
Total changes in ownership interests in subsidiariesSGD thousand (91)–––––––––(91) PDF p. 151
Lapses of employees’ share optionsSGD thousand –475–––––––475(475) PDF p. 151
Total othersSGD thousand –475–––––––475(475) PDF p. 151
Closing balance at 30 June 2025SGD thousand 548,429470,8952,364,503(1,842,369)(117,800)(47,128)2,519521(691)111,34077,534 PDF p. 151
Definitions & sources

Company Equity Movements 2026

8 metrics

Units appear below each metric. Scroll to compare years

Company Equity Movements 2026 from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026CompanyTotal equity2026CompanyShare capital2026CompanyRetained earnings / accumulated losses2026CompanyHedging reserve2026CompanyShare-based payment reserve Source
Company equity movements
Opening balance at 1 July 2025SGD thousand 2,416,5382,364,50352,205(691)521 PDF p. 152
Profit for the year, representing total comprehensive income for the yearSGD thousand 19,584–19,584–– PDF p. 152
Net change in fair value of cash flow hedgesSGD thousand 243––243– PDF p. 152
Equity-settled share-based payment transactionsSGD thousand 72–––72 PDF p. 152
Vesting of shares under Share Grant Plan 2015SGD thousand –194––(194) PDF p. 152
Total contributions by ownersSGD thousand 72194––(122) PDF p. 152
Transfer of share-based payment reserveSGD thousand ––399–(399) PDF p. 152
Closing balance at 30 June 2026SGD thousand 2,436,4372,364,69772,188(448)– PDF p. 152
Definitions & sources

Company Equity Movements 2025

6 metrics

Units appear below each metric. Scroll to compare years

Company Equity Movements 2025 from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2025CompanyTotal equity2025CompanyShare capital2025CompanyRetained earnings / accumulated losses2025CompanyHedging reserve2025CompanyShare-based payment reserve Source
Company equity movements
Opening balance at 1 July 2024SGD thousand 2,363,0602,364,503(2,241)76722 PDF p. 152
Profit for the year, representing total comprehensive income for the yearSGD thousand 54,446–54,446–– PDF p. 152
Net change in fair value of cash flow hedgesSGD thousand (767)––(767)– PDF p. 152
Equity-settled share-based payment transactionsSGD thousand (201)–––(201) PDF p. 152
Total contributions by ownersSGD thousand (201)–––(201) PDF p. 152
Closing balance at 30 June 2025SGD thousand 2,416,5382,364,50352,205(691)521 PDF p. 152
Definitions & sources

Cash and Short-term Deposit Composition

3 metrics

Units appear below each metric. Scroll to compare years

Cash and Short-term Deposit Composition from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group2026Company2025Company Source
Cash and Short-term Deposit Composition
Cash at banks and on handSGD thousand 58,04172,8386,5673,999 PDF p. 198
Short-term depositsSGD thousand 55,04251,37318,30021,784 PDF p. 198
Cash and short-term depositsSGD thousand 113,083124,21124,86725,783 PDF p. 198
Definitions & sources

Cash Flow Cash Reconciliation

3 metrics

Units appear below each metric. Scroll to compare years

Cash Flow Cash Reconciliation from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group Source
Cash Flow Cash Reconciliation
Cash and short-term depositsSGD thousand 113,083124,211 PDF p. 198
Less: Pledged depositsSGD thousand (7,977)(10,192) PDF p. 198
Cash and cash equivalentsSGD thousand 105,106114,019 PDF p. 198
Definitions & sources

Five-year Financial Summary

11 metrics

Units appear below each metric. Scroll to compare years

Five-year Financial Summary from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group2024Group2023Group2022Group Source
Five-year Financial Summary
RevenueSGD million 420.1394.7351.2355.8333.7 PDF p. 53
EBITDASGD million 67.354.6101.9103.3109.7 PDF p. 53
Operating profitSGD million 26.315.973.585.591.8 PDF p. 53
Profit/(Loss) before taxSGD million (21.1)(40.6)29.255.269.3 PDF p. 53
Profit/(Loss) after taxSGD million (27.8)(47.0)18.241.158.6 PDF p. 53
Profit/(Loss) attributable to owners of the CompanySGD million (29.7)(47.6)14.236.653.8 PDF p. 53
Cash and bank balancesSGD million 113.1124.2167.3286.6161.6 PDF p. 53
Debt and borrowingsSGD million 1,107.11,105.91,106.2747.8629.1 PDF p. 53
Total assetsSGD million 1,774.21,784.61,809.41,447.81,364.9 PDF p. 53
Net assetsSGD million 525.5548.4577.0575.4608.3 PDF p. 53
Shareholders’ equitySGD million 442.4470.9499.7499.4531.7 PDF p. 53
Definitions & sources

Loans and Borrowings Composition

7 metrics

Units appear below each metric. Scroll to compare years

Loans and Borrowings Composition from Thomson Medical Group Limited Annual Report 2026
Metric / unit 2026Group2025Group2026Company2025Company Source
Loans and Borrowings Composition
Current secured bank loansSGD thousand 26,845163,94312,50097,433 PDF p. 199
Current medium-term notesSGD thousand 175,000–175,000– PDF p. 199
Total current interest-bearing loans and borrowingsSGD thousand 201,845163,943187,50097,433 PDF p. 199
Non-current secured bank loansSGD thousand 542,456407,596275,659197,050 PDF p. 199
Non-current medium-term notesSGD thousand 359,517534,372359,517534,372 PDF p. 199
Total non-current interest-bearing loans and borrowingsSGD thousand 901,973941,968635,176731,422 PDF p. 199
Total interest-bearing loans and borrowingsSGD thousand 1,103,8181,105,911822,676828,855 PDF p. 199
Definitions & sources

Where the money comes from

Segment information

By business

Segment information 2026 (by operating segment) 11 lines
Segment information 2026 (by operating segment)
Item / unit 2026Singapore2026Malaysia2026Vietnam2026Investment holdings2026Consolidated Source
Revenue
External customers$'000 192,860125,337101,338545420,080 PDF p. 213
Total revenue$'000 192,860125,337101,338545420,080 PDF p. 213
Results
Finance income$'000 92903487541,797 PDF p. 213
Finance costs$'000 (2,481)(2,366)(439)(43,917)(49,203) PDF p. 213
Share of results of joint venture and associate$'000 –––(17)(17) PDF p. 213
Depreciation and amortisation$'000 (17,668)(11,941)(10,968)(405)(40,982) PDF p. 213
Impairment loss on goodwill$'000 –––(15,245)(15,245) PDF p. 213
Segment profit/(loss)$'000 22,5645,3302,963(58,647)(27,790) PDF p. 213
Assets
Additions to non-current assets$'000 24,1076,98410,5563141,678 PDF p. 213
Segment assets$'000 673,409411,161365,493324,1491,774,212 PDF p. 213
Liabilities
Segment liabilities$'000 147,07380,18723,276998,1901,248,726 PDF p. 213
Notes

Note A: Additions to non-current assets consist of additions to property and equipment, intangible assets, right-of-use assets and investment in associate.

Segment performance is evaluated based on operating profit or loss which in certain respects is measured differently from operating profit or loss in the consolidated financial statements. Investment holdings are mainly those relating to investment properties and development property.

Segment information 2025 (by operating segment) 13 lines
Segment information 2025 (by operating segment)
Item / unit 2025Singapore2025Malaysia2025Vietnam2025Investment holdings2025Consolidated Source
Revenue
External customers$'000 190,400105,33998,446473394,658 PDF p. 214
Total revenue$'000 190,400105,33998,446473394,658 PDF p. 214
Results
Finance income$'000 1111,2622681,9753,616 PDF p. 214
Finance costs$'000 (2,891)(2,827)(455)(53,483)(59,656) PDF p. 214
Share of results of joint venture$'000 –––(483)(483) PDF p. 214
Depreciation and amortisation$'000 (15,889)(10,488)(11,879)(429)(38,685) PDF p. 214
Impairment loss on goodwill$'000 –––(75,134)(75,134) PDF p. 214
Reversal of impairment loss on development property$'000 –––26,59326,593 PDF p. 214
Reversal of impairment loss on investment properties$'000 –––28,02428,024 PDF p. 214
Segment profit/(loss)$'000 24,8649462,687(75,477)(46,980) PDF p. 214
Assets
Additions to non-current assets$'000 21,19610,9937,18357939,951 PDF p. 214
Segment assets$'000 664,078396,471400,237323,7971,784,583 PDF p. 214
Liabilities
Segment liabilities$'000 125,45185,76119,6061,005,3361,236,154 PDF p. 214
Notes

Note A: Additions to non-current assets consist of additions to property and equipment, intangible assets, right-of-use assets and investment in joint venture.

Comparative year (2025) segment table; printed on the continuation page of Note 36.

By geography

Geographical information - Revenue and non-current assets 4 lines
Geographical information - Revenue and non-current assets
Item / unit 2026Revenue2025Revenue2026Non-current assets2025Non-current assets Source
Geographical information
Singapore$'000 192,860190,400612,171609,727 PDF p. 214
Malaysia$'000 125,882105,812491,863471,727 PDF p. 214
Vietnam$'000 101,33898,446346,433383,580 PDF p. 214
Total (unlabelled)$'000 420,080394,6581,450,4671,465,034 PDF p. 214
Notes

Revenue and non-current assets information based on the geographical location of customers and assets respectively.

Non-current assets information presented above mainly consist of property and equipment, intangible assets, investment properties and right-of-use assets as presented in the consolidated statement of financial position.

Total row has no printed label.

Debt

Borrowings

Note 34(b) Lease liabilities contractual undiscounted maturity (blocks: Group 2026, Group 2025, Company 2026, Company 2025)

Note 34(b) Lease liabilities contractual undiscounted maturity (blocks: Group 2026, Group 2025, Company 2026, Company 2025)
Item / unit 2026Group: 1 year or less, 1 to 5 years, Over 5 years, Total2025Group: 1 year or less, 1 to 5 years, Over 5 years, Total2026Company: 1 year or less, 1 to 5 years, Over 5 years, Total2025Company: 1 year or less, 1 to 5 years, Over 5 years, Total Source
Group 2026
Lease liabilities (Group 2026)$'000 11,51717,1772,17730,871 PDF p. 211
Group 2025
Lease liabilities (Group 2025)$'000 9,0418,4052,35619,802 PDF p. 211
Company 2026
Lease liabilities (Company 2026)$'000 29937–336 PDF p. 211
Company 2025
Lease liabilities (Company 2025)$'000 295335–630 PDF p. 211
Notes

Each row's four values are 1 year or less, 1 to 5 years, Over 5 years, Total for the labelled scope-year block.

Borrowing notes 3 tables

Interest-bearing loans and borrowings

Interest-bearing loans and borrowings
Item / unit 2026Group2025Group2026Company2025Company Source
Current
Secured bank loans$'000 26,845163,94312,50097,433 PDF p. 199
Medium-term notes$'000 175,000–175,000– PDF p. 199
Non-current
Secured bank loans$'000 542,456407,596275,659197,050 PDF p. 199
Medium-term notes$'000 359,517534,372359,517534,372 PDF p. 199
Total
Total interest-bearing loans and borrowings$'000 1,103,8181,105,911822,676828,855 PDF p. 199
Notes

Current subtotals printed: Group 201,845 / 163,943; Company 187,500 / 97,433. Non-current subtotals: Group 901,973 / 941,968; Company 635,176 / 731,422.

Covenants: leverage ratios, net worth requirements, debt service cover ratio and security cover ratio; Group complied as at reporting date.

Company bank loans in SGD; rates 2.66% to 4.59% (2025: 4.03% to 5.98%) per annum; maturities 2027 to 2030 (2025: 2025 to 2027). Secured by charge over certain shares and assets of subsidiaries and corporate guarantees.

Subsidiary bank loans $281,142,000 (2025: $277,056,000), effective rates 2.66% to 5.17% (2025: 4.60% to 6.29%); denominated in Malaysian Ringgit except $236,098,000 (2025: $218,702,000) in SGD; maturities 2027 to 2031 (2025: 2025 to 2031).

MTN programme upsized from $500 million to $1 billion on 21 April 2023. Notes: Series 003 5.5% due May 2028 ($120m, $30m, $25m tranches); Series 004 5.25% due May 2027 ($155m, $20m); Series 005 4.65% due October 2029 ($160m, $25m). Interest payable semi-annually.

Lease liabilities carrying amount (current/non-current)

Lease liabilities carrying amount (current/non-current)
Item / unit 2026Group2025Group2026Company2025Company Source
Lease liabilities
Current$'000 10,1857,553290271 PDF p. 201
Non-current$'000 15,9818,10237326 PDF p. 201
At end of the year$'000 26,16615,655327597 PDF p. 201
Notes

Leases of land and premises generally have lease terms between 2 to 27 years, while equipment has lease term of 5 years.

Note 34(c) Interest rate profile of borrowings

Note 34(c) Interest rate profile of borrowings
Item / unit 2026Group2025Group2026Company2025Company Source
Variable rate instruments
Secured bank loans$'000 569,301571,539288,159294,483 PDF p. 212
Notes

100 basis points change would change Group profit before taxation by $5,693,000 (2025: $5,715,000).

Payout

Dividends & distributions

Dividend policy

ItemValuePeriod / scopeSource
Dividend Policy The Company does not have a policy on payment of dividend. The Board will consider the Group’s level of cash and retained earnings and projected capital expenditure and investments before proposing a dividend. Any payout of dividends declared being interim or final will be clearly communicated to shareholders in public announcements and via announcements on SGXNet when the Company discloses its financial results. Company PDF p. 128

Extracted from Thomson Medical Group Limited Annual Report 2026 and checked against the cited pages; see the original report for full context.

Auditor’s report

Audit & risk signals

Audit opinion

ItemValuePeriod / scopeSource
Auditor Ernst & Young LLP Group PDF p. 145
Engagement partner Peh Sharon Group PDF p. 145
Opinion properly drawn up in accordance with the provisions of the Companies Act 1967 (the “Act”) and Singapore Financial Reporting Standards (International) (“SFRS(I)”) so as to give a true and fair view Group and Company PDF p. 140

Key audit matters

ItemValuePeriod / scopeSource
Carrying value of goodwill attributable to Thomson Medical Pte Ltd, TMC Life Sciences Berhad and Far East Medical Vietnam Limited Given the magnitude of the carrying value of the CGUs and significant judgement and estimation involved in assessing the recoverable amounts, we have identified this as a key audit matter. Group PDF p. 141
Carrying value of goodwill and property and equipment attributable to BB Waterfront Sdn Bhd Given the magnitude of the carrying value of the CGU and significant judgement and estimation involved in assessing the recoverable amount of BBWF, we have identified this as a key audit matter. Group PDF p. 142
Carrying value of investment properties and development property located in Johor Bahru, Malaysia Given the magnitude of these assets and significant judgement associated with the inputs used in valuation, we have identified the carrying value of investment properties and development property located in Johor Bahru, Malaysia, as a key audit matter. Group PDF p. 142

Extracted from Thomson Medical Group Limited Annual Report 2026 and checked against the cited pages; see the original report for full context.

How to read these figures

Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.

Comparative figures follow Thomson Medical Group Limited Annual Report 2026, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.

Financial year ended30June2026; Group and Company scopes retained. Losses and negative reserves remain in original parentheses. EPS expressed in SGD cents, not SGD dollars.

Balance-sheet cash113.083million differs from cash-flow cash105.106million; originalNote24 reconciliation must be separately verified.

Group equity pages are rotated in PDF; extraction projects coordinates for column alignment but keeps original native coordinates as evidence.

FY2026 share vesting194thousand transfersfromsharebasedreservetocapitalwithno totalequity change. Transfer399thousand toretainedearnings is internalreserve movement.

FY2025 employee option lapse transfers475thousand fromNCI toownerretainedearnings; nochangeintotalequity.

Company original profit row says representing total comprehensive income; the same original statement separately shows hedge OCI243/negative767. Preserve source row wording, calculate total movements using separately disclosedOCI, not doublecount.

FY2026 consolidated cash113.083million lesspledgeddeposits7.977million equalsCFcash105.106million. OriginalNote24 includes fixed deposits with maturitymorethan3months in cash equivalents because of insignificant risk in value changes; do not impose another exclusion.

Five-year summary is SGDmillion roundedtoonedecimal; mainstatementsSGDthousand. FY2026 debt1,107.1* includes financelease3.3million as original footnote, whereas mainstatement loans1,103.818million exclude leases.

Historical Group shareholders’equity excludesnoncontrollinginterests; netassetsincludesNCI. Historical columns reversed consistently todescending2026–2022.

Group and Company borrowing composition is originalcarryingvalue; MTNprogrammeSGD1billion is authorisedcapacity, notoutstandingdebt. Group financialcovenants compliedwith atreportingdate peroriginalNote26.

No ordinary dividendpayment row appears inconsolidatedCF; NCIdividends507/3869thousand are distributions tosubsidiaryminorityholders, notordinaryTMGshareholders. Noordinarydividend recommendation inferredfrom absence.

These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.